# CLSDQ (Clearside Biomedical, Inc.) - SEC EDGAR Financial Statements

> Clearside Biomedical, Inc. reported $3.33M in revenue and a net loss of $26.00M for the trailing twelve months ended September 30, 2025 (down 80.6% year over year), with a 88.1% gross margin and a -689.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/CLSDQ
- Markdown: https://convexityos.com/fundamentals/CLSDQ.md
- SEC CIK: 0001539029
- Reporting currency: USD
- Latest filing period: September 30, 2025
- Last synced: Nov 21, 2026, 05:13 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001539029&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $3.33M | -80.6% YoY |
| Operating Income | TTM | -$22.96M | -689.8% margin |
| Net Income | TTM | -$26.00M | -780.9% net margin |
| Diluted EPS | TTM | -$4.97 | Split-adjusted |
| Free Cash Flow | TTM | -$21.75M | -653.2% FCF margin |
| Cash & ST Investments | Sep 30, 2025 | $6.80M | Total debt: $446K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.66M | $8.23M | $1.33M | $29.57M | $7.89M | $2.17M | $30K | $345K | $520K | -- |
| Cost of Revenue | $149K | $355K | $204K | $0 | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $1.51M | $7.87M | $1.12M | $29.57M | -- | -- | -- | -- | -- | -- |
| Research & Development | $18.59M | $20.85M | $19.63M | $18.54M | $15.07M | $15.66M | $68.29M | $49.05M | $19.45M | $10.76M |
| Total Operating Expenses | -- | $33.07M | $31.60M | $30.20M | $25.83M | $32.48M | $82.97M | $58.75M | $25.72M | $17.32M |
| **Operating Income** | -$28.88M | -$24.84M | -$30.28M | -$627K | -$17.93M | -$30.30M | -$82.94M | -$58.41M | -$25.20M | -$17.32M |
| **EBITDA** | -$29.22M | -$24.84M | -$30.28M | -$449K | -$17.75M | -$30.09M | -$82.76M | -$58.23M | -$25.13M | -$17.26M |
| Interest Income | $1.46M | $1.72M | $669K | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$34.35M | -$32.48M | -$32.95M | $376K | -$18.21M | -$30.77M | -$82.82M | -$58.98M | -$25.88M | -$17.64M |
| Basic EPS | -$7.05 | -$7.95 | -$8.25 | $0.15 | -$5.85 | -$12.15 | -$40.35 | -$34.95 | -$29.55 | -$113.10 |
| **Diluted EPS** | -$7.05 | -$7.95 | -$8.25 | $0.15 | -$5.85 | -$12.15 | -$40.35 | -$34.95 | -$29.55 | -$113.10 |
| Basic Shares Outstanding | 4.9M | 4.1M | 4.0M | 3.9M | 3.1M | 2.5M | 2.0M | 1.7M | 874.1K | 155.9K |
| Diluted Shares Outstanding | 4.9M | 4.1M | 4.0M | 4.0M | 3.1M | 2.5M | 2.0M | 1.7M | 874.1K | 155.9K |

### Income Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $201K | $492K | $2.33M | $306K | $1.04M | $90K | $230K | $6.34M |
| Cost of Revenue | $0 | $0 | $248K | $149K | $0 | $0 | $0 | -- |
| **Gross Profit** | $201K | $492K | $2.08M | $157K | $1.04M | $90K | $230K | -- |
| Research & Development | $2.93M | $1.58M | $4.46M | $4.24M | $4.13M | $4.60M | $5.62M | $6.31M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | $8.44M | $9.26M |
| **Operating Income** | -$7.04M | -$3.57M | -$5.21M | -$7.15M | -$5.93M | -$7.59M | -$8.21M | -$2.92M |
| **EBITDA** | -$6.96M | -$3.48M | -$5.12M | -$7.07M | -$5.86M | -$7.55M | -$8.18M | -$2.90M |
| Interest Income | $65K | $115K | $163K | $358K | $338K | $419K | $348K | $360K |
| Income Before Tax | -$5.97M | -$4.50M | -$7.51M | -- | -$7.69M | -$7.59M | -$11.76M | -- |
| Income Tax Expense | $0 | $0 | $715K | -- | $0 | $0 | $0 | -- |
| **Net Income** | -$5.97M | -$4.50M | -$8.22M | -$7.31M | -$7.69M | -$7.59M | -$11.76M | -$4.83M |
| Basic EPS | -$1.14 | -$0.90 | -$1.65 | -- | -$1.54 | -$1.50 | -$2.55 | -- |
| **Diluted EPS** | -$1.14 | -$0.90 | -$1.65 | -- | -$1.54 | -$1.50 | -$2.55 | -- |
| Basic Shares Outstanding | 5.2M | 5.2M | 5.1M | -- | 5.0M | 5.0M | 4.7M | -- |
| Diluted Shares Outstanding | 5.2M | 5.2M | 5.1M | -- | 5.0M | 5.0M | 4.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20.02M | $28.92M | $48.26M | $30.44M | $17.29M | $22.59M | $8.04M | $9.22M | $34.82M | $20.28M |
| Short-Term Investments | -- | $0 | -- | -- | -- | -- | $32.84M | $28.42M | $48.81M | -- |
| **Cash & Short-Term Investments** | $20.02M | $28.92M | $48.26M | $30.44M | $17.29M | $22.59M | $40.90M | $37.60M | $83.60M | $20.28M |
| Accounts Receivable, Net | $507K | $467K | $0 | $10.00M | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $13K | $14K | $439K | $779K | $109K | $1.49M | $17K | $116K | $290K | $40K |
| **Total Current Assets** | $21.27M | $30.12M | $49.40M | $42.14M | $18.12M | $25.22M | $42.94M | $39.20M | $84.32M | $20.48M |
| Property, Plant & Equipment, Net | $3.23M | $3.00M | $755K | $238K | $416K | $541K | $790K | $885K | $94K | $156K |
| Other Non-Current Assets | $30K | $30K | $30K | -- | -- | -- | $26K | $47K | $42K | $7.0K |
| **Total Non-Current Assets** | $3.85M | $3.90M | $1.90M | $767K | $1.20M | $1.56M | $1.18M | $1.29M | $496K | $573K |
| **Total Assets** | $25.13M | $34.02M | $51.30M | $42.90M | $19.32M | $26.78M | $44.12M | $40.49M | $84.81M | $21.05M |
| Accounts Payable | $1.45M | $2.21M | $1.05M | $941K | $2.00M | $1.28M | $6.87M | $5.38M | $2.59M | $1.47M |
| Short-Term Debt | -- | -- | -- | -- | $991K | $1.33M | $556K | $3.20M | -- | $1.73M |
| Deferred Revenue (Current) | $0 | $75K | $205K | $0 | $5.00M | $5.00M | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $20K | $20K | $9.0K |
| **Total Current Liabilities** | $4.79M | $6.81M | $5.78M | $4.64M | $9.94M | $10.90M | $10.48M | $13.52M | $5.41M | $5.20M |
| Long-Term Debt | -- | -- | -- | -- | -- | $3.82M | $9.42M | $4.81M | $7.59M | $4.24M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $140K | $160K | $700K |
| Other Non-Current Liabilities | $400K | $480K | $0 | -- | -- | -- | -- | -- | -- | $261K |
| **Total Non-Current Liabilities** | $59.19M | $43.12M | $34.91M | $288K | $616K | $4.72M | $10.02M | $5.56M | $7.75M | $5.20M |
| **Total Liabilities** | $63.98M | $49.93M | $40.70M | $4.93M | $10.56M | $15.62M | $20.50M | $19.08M | $13.15M | $10.40M |
| **Total Debt (incl. Leases)** | $703K | $1.01M | $1.28M | $675K | $1.98M | $6.41M | $9.97M | $8.01M | $7.59M | $5.98M |
| Common Stock | $77K | $63K | $61K | $60K | $52K | $44K | $32K | $25K | $25K | $3.0K |
| Retained Earnings | -$355.3M | -$320.9M | -$288.4M | -$255.5M | -$255.9M | -$237.7M | -$206.9M | -$124.2M | -$65.25M | -$39.36M |
| Accumulated Other Comp. Income | -- | $0 | -- | -- | -- | -- | -- | -$8.0K | -$13K | -- |
| **Total Stockholders' Equity** | -$38.85M | -$15.91M | $10.61M | $37.98M | $8.76M | $11.16M | $23.62M | $21.41M | $71.66M | -$36.66M |
| Total Equity | -$38.85M | -$15.91M | $10.61M | $37.98M | $8.76M | $11.16M | $23.62M | $21.41M | $71.66M | -$36.66M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.80M | $9.38M | $13.63M | $20.02M | $13.89M | $18.24M | $35.35M | $28.92M |
| Short-Term Investments | -- | -- | -- | -- | $9.70M | $11.12M | -- | $0 |
| **Cash & Short-Term Investments** | $6.80M | $9.40M | $13.60M | $20.02M | $23.60M | $29.40M | $35.35M | $28.92M |
| Accounts Receivable, Net | $266K | $816K | $1.54M | $507K | $788K | $0 | $0 | $467K |
| Other Current Assets | $0 | $13K | $77K | $13K | $13K | $44K | $193K | $14K |
| **Total Current Assets** | $8.25M | $11.79M | $15.96M | $21.27M | $25.11M | $29.77M | $36.12M | $30.12M |
| Property, Plant & Equipment, Net | $2.98M | $3.06M | $3.15M | $3.23M | $3.35M | $3.40M | $3.19M | $3.00M |
| Other Non-Current Assets | $30K | $30K | $30K | $30K | $30K | $30K | $30K | $30K |
| **Total Non-Current Assets** | $3.39M | $3.55M | $3.70M | $3.85M | $4.05M | $4.17M | $4.03M | $3.90M |
| **Total Assets** | $11.64M | $15.33M | $19.67M | $25.13M | $29.16M | $33.93M | $40.14M | $34.02M |
| Accounts Payable | $796K | $1.13M | $1.91M | $1.45M | $2.36M | $1.58M | $1.36M | $2.21M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $0 | $225K | $150K | $75K |
| **Total Current Liabilities** | $2.77M | $3.05M | $5.01M | $4.79M | $5.59M | $5.87M | $5.95M | $6.81M |
| Other Non-Current Liabilities | -- | -- | -- | $400K | -- | -- | -- | $480K |
| **Total Non-Current Liabilities** | $62.82M | $61.02M | $60.57M | $59.19M | $58.36M | $56.34M | $56.00M | $43.12M |
| **Total Liabilities** | $65.59M | $64.07M | $65.58M | $63.98M | $63.95M | $62.22M | $61.95M | $49.93M |
| **Total Debt (incl. Leases)** | $446K | $533K | $619K | $703K | $785K | $863K | $939K | $1.01M |
| Common Stock | $78K | $78K | $77K | $77K | $75K | $74K | $74K | $63K |
| Retained Earnings | -$374.0M | -$368.0M | -$363.5M | -$355.3M | -$348.0M | -$340.3M | -$332.7M | -$320.9M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $5.0K | -$1.0K | -- | $0 |
| **Total Stockholders' Equity** | -$53.95M | -$48.73M | -$45.91M | -$38.85M | -$34.79M | -$28.29M | -$21.81M | -$15.91M |
| Total Equity | -$53.95M | -$48.73M | -$45.91M | -$38.85M | -$34.79M | -$28.29M | -$21.81M | -$15.91M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$34.35M | -$32.48M | -$32.95M | $376K | -$18.21M | -$30.77M | -$82.82M | -$58.98M | -$25.88M | -$17.64M |
| Depreciation & Amortization | -$339K | $0 | $0 | $178K | $180K | $211K | $189K | $182K | $65K | $60K |
| Stock-Based Compensation | $4.51M | $4.20M | $4.88M | $5.05M | $3.60M | $4.61M | $4.79M | $3.36M | $1.31M | $705K |
| **Operating Cash Flow** | -$24.70M | -$18.14M | -$13.37M | -$10.73M | -$13.12M | -$27.07M | -$79.20M | -$51.08M | -$22.71M | -$13.90M |
| Capital Expenditure | -$977K | -$1.78M | -$246K | $0 | -$55K | -$25K | -$88K | -$306K | -$3.0K | -$32K |
| **Free Cash Flow** | -$25.68M | -$19.91M | -$13.61M | -$10.73M | -$13.18M | -$27.09M | -$79.29M | -$51.39M | -$22.71M | -$13.93M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -$80.14M | -$48.12M | -$54.48M | -- |
| **Investing Cash Flow** | -$638K | -$1.78M | -$246K | $0 | -$55K | $32.92M | -$3.76M | $20.12M | -$49.14M | -$28K |
| **Financing Cash Flow** | $16.44M | $414K | $31.33M | $23.78M | $7.87M | $8.70M | $81.78M | $5.36M | $86.39M | $25.94M |
| **Net Change in Cash** | -$8.90M | -$19.50M | $17.72M | $13.05M | -$5.31M | $14.55M | -$1.18M | -$25.60M | $14.54M | $12.01M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.97M | -$4.50M | -$8.22M | -$7.31M | -$7.69M | -$7.59M | -$11.76M | -$4.83M |
| Depreciation & Amortization | $84K | $84K | $85K | $79K | $75K | $44K | $28K | $20K |
| Stock-Based Compensation | $746K | $694K | $721K | $1.17M | $1.17M | $1.12M | $1.06M | $1.03M |
| **Operating Cash Flow** | -$5.48M | -$4.73M | -$5.83M | -$5.25M | -$5.91M | -$5.68M | -$7.85M | $495K |
| Capital Expenditure | $0 | $0 | -$9.0K | -$444K | -$53K | -$423K | -$57K | -$120K |
| **Free Cash Flow** | -$5.48M | -$4.73M | -$5.84M | -$5.70M | -$5.97M | -$6.10M | -$7.91M | $375K |
| **Investing Cash Flow** | $0 | $0 | -$9.0K | $9.31M | $1.55M | -$11.44M | -$57K | -$120K |
| **Financing Cash Flow** | $2.90M | $477K | -$553K | $2.08M | $14K | $0 | $14.34M | -$257K |
| **Net Change in Cash** | -$2.58M | -$4.25M | -$6.39M | $6.13M | -$4.35M | -$17.12M | $6.43M | $118K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 91.0% | 95.7% | 84.6% | 100.0% | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -1735.7% | -302.0% | -2281.6% | -2.1% | -227.2% | -1394.6% | -276483.3% | -16929.9% | -4845.8% | -- |
| **Net Profit Margin** | -2064.4% | -394.9% | -2482.8% | 1.3% | -230.7% | -1416.0% | -276060.0% | -17094.2% | -4977.3% | -- |
| Return on Equity (ROE) | -- | -- | -310.6% | 1.0% | -207.8% | -275.8% | -350.6% | -275.4% | -36.1% | -- |
| Return on Assets (ROA) | -136.7% | -95.5% | -64.2% | 0.9% | -94.2% | -114.9% | -187.7% | -145.6% | -30.5% | -83.8% |
| Current Ratio | 4.44x | 4.42x | 8.54x | 9.08x | 1.82x | 2.31x | 4.10x | 2.90x | 15.59x | 3.94x |
| Quick Ratio | 4.28x | 4.31x | 8.34x | 8.71x | 1.74x | 2.07x | 3.90x | 2.78x | 15.46x | 3.90x |
| Debt to Equity | -- | -- | 0.12x | 0.02x | 0.23x | 0.57x | 0.42x | 0.37x | 0.11x | -- |
| **Revenue Growth (YoY)** | -79.8% | +519.9% | -95.5% | +274.7% | +263.3% | +7143.3% | -91.3% | -33.7% | -- | -- |
| Gross Profit Growth (YoY) | -80.8% | +600.9% | -96.2% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -8862.5% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -5600.0% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -60.4% | +13534.6% | +61.7% | +1174.9% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 88.1% | 90.5% | 89.5% | 91.0% | -- | -- | -- | -- |
| **Operating Margin** | -689.8% | -524.6% | -687.5% | -1735.7% | -320.0% | -342.5% | -301.1% | -302.0% |
| **Net Profit Margin** | -780.9% | -665.2% | -818.6% | -2064.4% | -413.8% | -444.7% | -413.7% | -394.9% |
| Return on Assets (ROA) | -223.3% | -180.7% | -156.7% | -136.7% | -109.3% | -98.6% | -87.1% | -95.5% |
| Current Ratio | 2.98x | 3.87x | 3.19x | 4.44x | 4.49x | 5.07x | 6.07x | 4.42x |
| Quick Ratio | 2.55x | 3.35x | 3.02x | 4.28x | 4.36x | 5.01x | 5.94x | 4.31x |
| **Revenue Growth (YoY)** | -80.6% | +446.7% | +913.0% | -95.2% | +20.8% | -91.2% | +5650.0% | +1822.7% |
| Gross Profit Growth (YoY) | -80.6% | +446.7% | +805.2% | -- | +44.8% | -88.8% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -1161.4% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -1619.5% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
